The acquisition of Irvine-based Cardiac Science Inc. is a step closer to wrapping up.
The maker of automatic heart defibrilltors said Monday it has set an Aug. 31 date for shareholders to vote on the proposed combination of Cardiac Science and Bothell, Wash.-based Quinton Cardiology Systems Inc.
The vote is set to take place at Newport Beach law firm Stradling Yocca Carlson & Rauth.
Cardiac Science said the Securities and Exchange Commission approved the registration statement that outlines the deal.
The companies expect to mail out the prospectus on Wednesday.
Quinton and Cardiac Science agreed to combine in February. Quinton shareholders are set to get about three-quarters of a share in the new company for each share of Quinton stock.
Shareholders of Cardiac Science would get a tenth of a share in the new company for every share of their existing stake.
The new Cardiac Science headquarters will be in Bothell. The company plans to keep research and development operations in Lake Forest.
In June, some shareholders looking to block the combination agreed to give up the fight.
In return, Cardiac Science said it would provide more information on its pending deal with Quinton.
